CADAS138 presents itself as a novel therapeutic target in the realm of inflammatory conditions. Preclinical studies indicate significant potential for CADAS138-targeted therapies to reduce disease progression. https://pennytmgc164709.blogdigy.com/a-potential-therapeutic-strategy-63488615